I recently read an interesting article from Fiercebiotech.com that highlights 10 late-stage cancer drugs that “represent the advancement of relatively new methods of attacking cancer, including “armed antibodies” and cancer-killing viruses.”

1. Carfilzomib – multiple myeloma 2. Crizotinib (PF-02341066) – lung cancer 3. GDC-0449 (vismodegib) – basal cell carcinoma 4. OncoVex – advanced melanoma 5. PLX4032 (RG7204) – melanoma 6. Ponatinib – leukemia 7. SGN-35 (brentuximab vedotin) – Hodgkin’s lymphoma, anaplastic large cell lymphomas 8. Tivozanib (AV-951) – advanced renal cell carcinoma 9. T-DM1 (Trastuzumab-DM1) – breast cancer 10. XL184 (cabozantinib) –  prostate cancer